Combinase AQ (Dymista)140/50 Mcg
USD $18.28 Add to cart

Combinase AQ (Dymista)140/50 Mcg

USD $18.28

Each Combinase contains Azelastine and Fluticasone. It is used to relieve symptoms such as sneezing, nasal congestion, runny nose, etc …

ATC Classification: R01AD58
Active Ingrediant: Azelastine and Fluticasone
Generic Name: Combinase AQ
Manufacturer: German Remedies
Strength: 140/50 Mcg
Dosage Type: Metered dosage
Packaging Type: Inhaler Unit
Contains: 70 MD

Examples of Packages sent

Description

Azelastine and Fluticasone Information


Pronunciation

a ZEL as teen & floo TIK a sone

 

What is this drug used for?

– It is used to ease allergy signs.

Frequently reported side effects of this drug

– Headache

– Change in taste

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

– Infection

– Adrenal gland problems like severe nausea, vomiting, severe dizziness, passing out, muscle weakness, severe fatigue, mood changes, lack of appetite, or weight loss

– Severe nose irritation

– Runny nose

– Nose crusting

– Wheezing

– Vision changes

– Eye pain

– Severe eye irritation

– Severe nosebleed

– Fatigue

– Thrush

– Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

 

Storage and Stability

Store at 20?C to 25?C (68?F to 77?F); do not refrigerate or freeze. Protect from light. Store in upright position with cap on.

 

Adverse Reactions

Reactions reported with combination product; also see individual agents.

Central nervous system: Headache

Gastrointestinal: Dysgeusia

Respiratory: Epistaxis (frequency and severity may be increased in children)

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Brand

German Remedies

Reviews

There are no reviews yet.

Be the first to review “Combinase AQ (Dymista)140/50 Mcg”

Your email address will not be published. Required fields are marked *